Double-Blind, Randomized, Multiple-Dose, Placebo-Controlled, 2-Way Crossover Study To Study Effects of PF-04457845 On Polysomnographic Endpoints In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2010
At a glance
- Drugs PF 4457845 (Primary)
- Indications Pain
- Focus Pharmacodynamics
- Sponsors Pfizer
- 14 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 14 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.